Investigator site audits and gcp compliance shehnaz v2.0

33
Investigator Site Audits and GCP Compliance Shehnaz Vakharia Principal Consultant Theraverity

Transcript of Investigator site audits and gcp compliance shehnaz v2.0

Page 1: Investigator site audits and gcp compliance shehnaz v2.0

Investigator Site Audits and GCP Compliance

• Shehnaz Vakharia• Principal Consultant• Theraverity

Page 2: Investigator site audits and gcp compliance shehnaz v2.0

Disclaimer

• The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated.

• These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws. Used by permission. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners.

Page 3: Investigator site audits and gcp compliance shehnaz v2.0

Background

0

20

40

60

80

100

Audits

Investigator Site

Systems

Investigato

r site

audits

Page 4: Investigator site audits and gcp compliance shehnaz v2.0

Where do we stand ?

Page 5: Investigator site audits and gcp compliance shehnaz v2.0

Awareness Vs Documented Training

0

20

40

60

80

100

Awareness

ICH GCP

Schedule Y

CDSCO GCP

Investigato

r sites a

udited

Page 6: Investigator site audits and gcp compliance shehnaz v2.0

Awareness / Documented Training

0

20

40

60

80

100

Documented Training

ICH GCP

Schedule Y

CDSCO GCP

Investigato

r sites a

udited

Page 7: Investigator site audits and gcp compliance shehnaz v2.0

Institutional Ethics Committee Vs Independent Ethics Committee

0

10

20

30

40

50

60

70

80

90

100

Hospitals Clinics

Institutional EC

Independent EC

% o

f In

vestigato

r sites

Page 8: Investigator site audits and gcp compliance shehnaz v2.0

Ethics Committee compliance to Schedule Y requirements

0

10

20

30

40

50

60

70

80

90

100

Chairman Members Quorum CTA

Institutional EC

Investigato

r site

s

Ethics Committee

Page 9: Investigator site audits and gcp compliance shehnaz v2.0

Compliance to EC requirements

010203040506070

8090

100

Annual

Reports

SAEs SAE Other

Investigator

Investigator

Sponsor / CRO

Investigato

r sites

During Study

Page 10: Investigator site audits and gcp compliance shehnaz v2.0

SOP & Compliance

0

10

20

30

40

50

60

70

80

90

100

Ethics

Committees

Investigator

Sites

SOPs

SOP compliance

Investigato

r sites

Page 11: Investigator site audits and gcp compliance shehnaz v2.0

SOP Training

0

10

20

30

40

50

60

70

80

90

100

Ethics Committees Investigator Sites

SOPs

Investigato

r sites

Page 12: Investigator site audits and gcp compliance shehnaz v2.0

Inherent Issues

Lack of Past Medical Records

Page 13: Investigator site audits and gcp compliance shehnaz v2.0

Inherent Issues

Documentation Practice & Data Reliability

Page 14: Investigator site audits and gcp compliance shehnaz v2.0

Documentation Practice

Changes

File Notes

Inadvertently!!!!!!

Insertions

Cancellations

Back-dating

Page 15: Investigator site audits and gcp compliance shehnaz v2.0

Documentation Issues

The source document and the CRF showed the test was performed on 06-Jul-09

The film of the scan however, showed

that the scan had been performed on

08-Jul-09

The subject had been source verified!!!!!!

Page 16: Investigator site audits and gcp compliance shehnaz v2.0

Source data supporting the Inclusion Criteria

Documentation Issues

Page 17: Investigator site audits and gcp compliance shehnaz v2.0

Qualifying ECG in a Cardiology study

Documentation Issues

Page 18: Investigator site audits and gcp compliance shehnaz v2.0

Report supporting the primary efficacy parameters of the study

Documentation Issues

CRF had recorded the initial lesion measurement

Page 19: Investigator site audits and gcp compliance shehnaz v2.0

Ethics Committee-Documentation Issues

Version numbers and Version dates

Date of signatures

Different letters issued on same dates

Missing links

Page 20: Investigator site audits and gcp compliance shehnaz v2.0

Registration System

0

10

20

30

40

50

60

70

80

90

100

Institution Private Clinics

In-patientRegistration

OPD Registration

Routine Follow-up Visits

Clinical TrialFollow-upIn

vesti

gato

r sit

es a

ud

ited

Page 21: Investigator site audits and gcp compliance shehnaz v2.0

Unique Identifier

0

10

20

30

40

50

60

70

80

90

100

Institution Private Clinics

In-patientRegistration

OPD Registration

Routine Follow-up Visits

Clinical TrialFollow-up

Investi

gato

r sit

es a

ud

ited

Practically impossible to cross check past visits

Page 22: Investigator site audits and gcp compliance shehnaz v2.0

Temperature Monitoring Documentation

Do we identify the storage location on the Temperature Monitoring Logs ?

Do we identify the monitoring device on the Temperature Monitoring Logs ?

Calibration of Temperature Monitoring Device?

Page 23: Investigator site audits and gcp compliance shehnaz v2.0

Sample Storage & Documentation

Do we have systems, processes & documentation for collection of clinical laboratory samples?

Do we have systems, processes & documentation for storage of clinical laboratory samples?

Do we have documentation of shipment of clinical laboratory samples?

Page 24: Investigator site audits and gcp compliance shehnaz v2.0

FacilityIn

vestigato

r sites

01020

3040

5060708090

100

Storage Archival Power Back-

up

Fire

Protection

Institutions

Clinics

Page 25: Investigator site audits and gcp compliance shehnaz v2.0

Calibration Records

Filed in the Investigator Site File? Yes

Comparable to the instruments? Not always

Page 26: Investigator site audits and gcp compliance shehnaz v2.0

HOWEVER, ON A POSITIVE NOTE…..

Page 27: Investigator site audits and gcp compliance shehnaz v2.0
Page 28: Investigator site audits and gcp compliance shehnaz v2.0

0

1

2

3

4

5

6

7

8

2005 2006 2007 2008 2009 2010

US FDA Inspection

US FDA Inspections -India

Investi

ga

tor

sit

es

INDIA

Page 29: Investigator site audits and gcp compliance shehnaz v2.0
Page 30: Investigator site audits and gcp compliance shehnaz v2.0

US FDA Inspection Results

09 of 17 Investigator Sites had ‘NAI’

No Action Indicated. No objectionable conditions or practices were

found during the inspection.

07 of 17 Investigator Sites had ‘VAI’Voluntary Action Indicated. Objectionable conditions were found but the problems do not justify further regulatory action. Any corrective action is left to the investigator to take voluntarily.

01 of 17 Investigator Sites had ‘VAI2’No response requested.

None of them resulted in ‘OAI’

Page 31: Investigator site audits and gcp compliance shehnaz v2.0

US FDA Inspection Results

Deficiency codes

04: Inadequate drug accountability

05: Failure to follow investigational plan

06: Inadequate and inaccurate records 0

1

2

3

4

5

6

7

4 5 6

US FDA Inspection

Investi

ga

tor

sit

es

Deficiency Code

Page 32: Investigator site audits and gcp compliance shehnaz v2.0

If we are able to overcome our documentation deficiencies we can

certainly take clinical research in India to a different level!!

Page 33: Investigator site audits and gcp compliance shehnaz v2.0

Thank You